Yves Gruel

11PUBLICATIONS
50CO-AUTHORS
HaematologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 17, 2023
Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?

Amrita Sarkar, Sanjay Khandelwal, Gavin T Koma

|Sep 07, 2022
Breast cancer cell-based ELISA: a potential material for better detection of heparin-induced thrombocytopenia antibodies.

Li-Yu Chen, Uwe Schirmer, Miriam Widder

|Aug 16, 2022
Variable serotonin release assay pattern and specificity of PF4-specific antibodies in HIT, and clinical relevance.

Jérôme Rollin, Noémie Charuel, Yves Gruel

|May 09, 2022
Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia.

Jason B Giles, Heidi E Steiner, Jerome Rollin

|Jul 31, 2021
Reply to the letter entitled "Suggested treatment of serious complications to Covid-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme".

Yves Gruel, Caroline Vayne, Jérôme Rollin

Pageof 2